BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

423 related articles for article (PubMed ID: 1379144)

  • 1. Angiotensin converting enzyme inhibitors versus digoxin for the treatment of congestive heart failure.
    Crozier I; Ikram H
    Drugs; 1992 May; 43(5):637-50. PubMed ID: 1379144
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Digoxin and angiotensin-converting enzyme inhibitors in the treatment of chronic congestive heart failure].
    Thery C
    Therapie; 1994; 49(3):211-8. PubMed ID: 7878586
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Angiotensin-converting enzyme inhibitors in heart failure: new strategies justified by recent clinical trials.
    Young JB
    Int J Cardiol; 1994 Feb; 43(2):151-63. PubMed ID: 8181869
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of angiotensin-converting enzyme inhibitors and digoxin on health outcomes of very old patients with heart failure. SAGE Study Group. Systematic Assessment of Geriatric drug use via Epidemiology.
    Gambassi G; Lapane KL; Sgadari A; Carbonin P; Gatsonis C; Lipsitz LA; Mor V; Bernabei R
    Arch Intern Med; 2000 Jan; 160(1):53-60. PubMed ID: 10632305
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Review of randomized trials of digoxin therapy in patients with chronic heart failure.
    Gheorghiade M; Zarowitz BJ
    Am J Cardiol; 1992 Jun; 69(18):48G-62G; discussion 62G-63G. PubMed ID: 1626492
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Angiotensin II receptor antagonists and heart failure: angiotensin-converting-enzyme inhibitors remain the first-line option.
    Prescrire Int; 2005 Oct; 14(79):180-6. PubMed ID: 16285075
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Congestive heart failure: what should be the initial therapy and why?
    Chatterjee K
    Am J Cardiovasc Drugs; 2002; 2(1):1-6. PubMed ID: 14727993
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Can further benefit be achieved by adding flosequinan to patients with congestive heart failure who remain symptomatic on diuretic, digoxin, and an angiotensin converting enzyme inhibitor? Results of the flosequinan-ACE inhibitor trial (FACET).
    Massie BM; Berk MR; Brozena SC; Elkayam U; Plehn JF; Kukin ML; Packer M; Murphy BE; Neuberg GW; Steingart RM
    Circulation; 1993 Aug; 88(2):492-501. PubMed ID: 8339411
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Pharmacologic treatment of chronic congestive heart failure].
    Halawa B
    Przegl Lek; 1996; 53(3):119-23. PubMed ID: 8754362
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Therapy of left ventricular dysfunction: implications of recent therapeutic trials and future directions for therapy.
    Pitt B
    Schweiz Med Wochenschr; 1993 Feb; 123(8):342-8. PubMed ID: 8095738
    [TBL] [Abstract][Full Text] [Related]  

  • 11. ACE inhibitors: myocardial infarction and congestive heart failure.
    Cody RJ
    Am Fam Physician; 1995 Nov; 52(6):1801-6. PubMed ID: 7484690
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Impact of angiotensin-converting enzyme inhibitor underdosing on rehospitalization rates in congestive heart failure.
    Luzier AB; Forrest A; Adelman M; Hawari FI; Schentag JJ; Izzo JL
    Am J Cardiol; 1998 Aug; 82(4):465-9. PubMed ID: 9723634
    [TBL] [Abstract][Full Text] [Related]  

  • 13. From digoxin to angiotensin-converting enzyme inhibitors: issues in pharmacotherapy for congestive heart failure.
    Hackenbruck HA
    Clin Excell Nurse Pract; 2000 Jul; 4(4):197-204. PubMed ID: 11261079
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Is there an expanded role for digoxin in patients with heart failure and sinus rhythm? A protagonist viewpoint.
    Williamson KM; Patterson JH
    Ann Pharmacother; 1997; 31(7-8):888-92. PubMed ID: 9220052
    [TBL] [Abstract][Full Text] [Related]  

  • 15. ACE inhibitors in congestive heart failure.
    Riegger AJ
    Cardiology; 1989; 76 Suppl 2():42-9. PubMed ID: 2670220
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The effects of enalapril-digoxin-diuretic combination therapy on nutritional and anthropometric indices in chronic congestive heart failure: preliminary findings in cardiac cachexia.
    Adigun AQ; Ajayi AA
    Eur J Heart Fail; 2001 Jun; 3(3):359-63. PubMed ID: 11378008
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Left ventricular diastolic heart failure with normal left ventricular systolic function in older persons.
    Aronow WS
    J Lab Clin Med; 2001 May; 137(5):316-23. PubMed ID: 11329528
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Fundamental role of angiotensin-converting enzyme inhibitors in the management of congestive heart failure.
    Opie LH
    Am J Cardiol; 1995 Jun; 75(18):3F-6F. PubMed ID: 7778532
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of angiotensin-converting enzyme inhibitors on ventricular remodeling and survival following myocardial infarction.
    Beckwith C; Munger MA
    Ann Pharmacother; 1993 Jun; 27(6):755-66. PubMed ID: 8329800
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Angiotensin-converting enzyme inhibitors in congestive heart failure.
    Deedwania PC
    Arch Intern Med; 1990 Sep; 150(9):1798-805. PubMed ID: 2132302
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 22.